Table 1.
Stage I/II (local): n = 9 (4%); curable |
Stage III+ (regionally advanced): n = 208 (87%); cure unlikely |
Stage IV (distant metastases): n = 21 (9%); incurable |
Stage I/II (local): n = 9 (4%); curable |
Stage III+ (regionally advanced): n = 208 (87%); cure unlikely |
Stage IV (distant metastases): n = 21 (9%); incurable |